Add to ORKGThe aim of this presentation is to illustrate a public health surveillance method for monitoring antiretroviral drug resistance (ADR) in persons diagnosed with human immunodeficiency virus infection (HIV). We developed procedures for examining HIV related electronic laboratory reports (ELR) transmitted to our health department surveillance system that link to corresponding clinical and demographic data for patients with varying degrees of antiretroviral drug resistance
A comprehensive, multifaceted approach to HIV surveillance is needed to provide the information nece...
HIV drug resistance (HIVDR) testing is not routinely available in many resource-limited settings, th...
New information about the benefits and limitations of testing for resistance to human immunodeficien...
In recent years the transmission of HIV drug-resistant strains among infected persons has been an on...
Background: The World Health Organization (WHO) HIV drug resistance (HIVDR) threshold survey method ...
Human immunodeficiency virus (HIV) RNA testing and HIV drug resistance (HIVDR) testing are not routi...
Human immunodeficiency virus (HIV) RNA testing and HIV drug resistance (HIVDR) testing are not routi...
Widespread use of antiretroviral agents and the epidemic of human immunodeficiency virus (HIV) strai...
With rapidly increasing access to antiretroviral drugs globally, HIV drug resistance (HIVDR) has bec...
HIV/AIDS is a global public health crisis that is yet to be contained. Effective management of HIV d...
AbstractThe laboratory tests currently available to the clinician for day-to-day management of HIV i...
The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Or...
The laboratory tests currently available to the clinician for day-to-day management of HIV infection...
The World Health Organization (WHO) estimates that >2 million people will have started antiretrovira...
Objective: To estimate the rate of acute and recent HIV infections and the prevalence of primary ant...
A comprehensive, multifaceted approach to HIV surveillance is needed to provide the information nece...
HIV drug resistance (HIVDR) testing is not routinely available in many resource-limited settings, th...
New information about the benefits and limitations of testing for resistance to human immunodeficien...
In recent years the transmission of HIV drug-resistant strains among infected persons has been an on...
Background: The World Health Organization (WHO) HIV drug resistance (HIVDR) threshold survey method ...
Human immunodeficiency virus (HIV) RNA testing and HIV drug resistance (HIVDR) testing are not routi...
Human immunodeficiency virus (HIV) RNA testing and HIV drug resistance (HIVDR) testing are not routi...
Widespread use of antiretroviral agents and the epidemic of human immunodeficiency virus (HIV) strai...
With rapidly increasing access to antiretroviral drugs globally, HIV drug resistance (HIVDR) has bec...
HIV/AIDS is a global public health crisis that is yet to be contained. Effective management of HIV d...
AbstractThe laboratory tests currently available to the clinician for day-to-day management of HIV i...
The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Or...
The laboratory tests currently available to the clinician for day-to-day management of HIV infection...
The World Health Organization (WHO) estimates that >2 million people will have started antiretrovira...
Objective: To estimate the rate of acute and recent HIV infections and the prevalence of primary ant...
A comprehensive, multifaceted approach to HIV surveillance is needed to provide the information nece...
HIV drug resistance (HIVDR) testing is not routinely available in many resource-limited settings, th...
New information about the benefits and limitations of testing for resistance to human immunodeficien...